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Background
End Stage Renal Disease (ESRD) is influenced by genetic
and epigenetic factors. Few studies have been reported
earlier depicting the role of Matrix Metalloproteinase in
different populations for ESRD risk, but we have reported
few novel and functional genes in North Indian popula-
tion. The prime objective of the present study was to find
out the association of four variants viz. MMP1-519(A/G)
and MMP1-1607(1G/2G) and MMP3+5356(A/G) and
MMP3 -1161(A/G) with ESRD risk.
Materials and methods
4 SNPs were genotyped by Polymerase Chain Reaction-
Restriction Fragment Length Polymorphism (PCR-RFLP)
in 200 ESRD patients and 200 healthy controls, that were
age and gender matched. To evaluate the SNP effects on
ESRD, odds ratio (OR) and confidence interval (CI) 95%
were calculated by SPSSver16.0. Haplotype analysis was
done for MMP1 by SNPanalyzer1.2 ver.
Results
In case of MMP1-519(A/G) the variant genotype GG
showed significant reduced risk of ESRD (p=0.005,
OR=0.254). On combining the heterozygous and variant
genotypes marginal reduced risk was observed (p=0.055,
OR=0.677), although we found significance reduced risk of
ESRD (p=0.007, OR=0.639) in G allele. In case of MMP1-
1607(1G/2G) the variant genotype 2G2G showed signifi-
cant reduced risk of ESRD (p=0.008, OR=0.476) whereas
the combination of heterozygous and variant genotypes
reduced risk was obtained (p=0.027, OR=0.614). At allelic
level, 2G allele showed reduced risk (p=0.006, OR=0.675)
of ESRD. Gene-gene interaction was also performed for
above gene variants. We found a significant reduced risk
in combination GG+AA (p=0.034, OR=0.185) on interact-
ing MMP1-519(A/G) and MMP3-1161(A/G). We also
found reduced risk for ESRD for MMP1-519(A/G) and
MMP1-1607(1G/2G) while looking risk for ESRD at hap-
lotype level. Bioinformatics analysis (in-silico) showed no
association with ESRD.
Conclusions
Our results indicated that polymorphism in MMP1-519
(A/G) and MMP1-1607(1G/2G) showed reduced risk for
ESRD in North-Indian population. More relevant studies
with large sample size and diverse ethnicity are required
to validate these observations.
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